Z. Lázár (Budapest, Hungary), A. Sinha (Amsterdam, Netherlands)
Impact of systemic inflammation on frequency and severityof mental disorders in COPD patients (pts) Y. Huba (Dnipro, Ukraine), L. Konopkina (Dnipro, Ukraine), T. Pertseva (Dnipro, Ukraine), D. Koval (Dnipro, Ukraine)
| |
Monitoring physical activity in COPD patients – a monocentric, prospective cohort study M. Bösch (St.Gallen, Switzerland), F. Rassouli (St.Gallen, Switzerland), V. Filipin-Horvath (St.Gallen, Switzerland), S. Widmer (St.Gallen, Switzerland), F. Baty (St.Gallen, Switzerland), M. Brutsche (St.Gallen, Switzerland)
| |
The underestimated subjectivity of the COPD assessment test R. Martins Natal (Guarda, Portugal), A. Pais (Lisbon, Portugal), J. M. R. Gama (Covilhã, Portugal), F. Rodrigues (Lisbon, Portugal), L. Vaz Rodrigues (Guarda, Portugal)
| |
Applying reference equations for 6-minute walking test in COPD and ILD patients D. Oliveira Reis (Vila Nova de Gaia, Portugal), P. Oliveira (Porto, Portugal), J. Gomes (Vila Nova de Gaia, Portugal), R. Lima (Vila Nova de Gaia, Portugal), M. Guimarães (Vila Nova de Gaia, Portugal), I. Ladeira (Vila Nova de Gaia, Portugal)
| |
Significance of brain network on physical activity among obstructive lung disease T. Hirano (Ube, Japan), T. Donishi (Wakayama, Japan), S. Takahashi (Wakayama, Japan), K. Suga (Ube, Japan), K. Doi (Ube, Japan), T. Tsukamoto (Ube, Japan), K. Murakawa (Ube, Japan), A. Chikumoto (Ube, Japan), Y. Ohteru (Ube, Japan), K. Matsuda (Ube, Japan), K. Hamada (Ube, Japan), R. Suetake (Ube, Japan), Y. Murata (Ube, Japan), K. Oishi (Ube, Japan), Y. Yamaji (Ube, Japan), M. Asami-Noyama (Ube, Japan), N. Edakuni (Ube, Japan), T. Kakugawa (Ube, Japan), K. Matsunaga (Ube, Japan)
| |
Clinical prognostic tools and their use in COPD. N. Lane (Newcastle Upon Tyne, United Kingdom), S. Gillespie (Newcastle Upon Tyne, United Kingdom), T. Hartley (Newcastle Upon Tyne, United Kingdom), C. Echevarria (Newcastle Upon Tyne, United Kingdom), J. Steer (Newcastle Upon Tyne, United Kingdom), S. Bourke (Newcastle Upon Tyne, United Kingdom)
| |
Assessment of thyroid function tests in COPD phenotypes A. YUKSEL (Ankara, Turkey), E. Akpinar (Ankara, Turkey), E. Sayin Gulensoy (Ankara, Turkey), N. Ogan (Ankara, Turkey), A. Alkan (Ankara, Turkey)
| |
Comparative Efficacy of Long-Acting Muscarinic Antagonists in COPD: Real Life Study E. Jusufovic (Tuzla, Bosnia and Herzegovina), V. Zugic (Belgrade, Republic of Serbia), M. Kosnik (Ljubljana, Slovenia), M. Jovancevic Drvenica (Sremska Kamenica, Republic of Serbia), S. Hromis (Sremska Kamenica, Republic of Serbia), J. Nurkic (Kuwait City, Kuwait), M. Al-Ahmad (Kuwait City, Kuwait), L. Bulat Kardum (Rijeka, Croatia), R. Sejdinovic (Tesanj, Bosnia and Herzegovina), B. Prnjavorac (Tesanj, Bosnia and Herzegovina), A. Jusufovic (Tuzla, Bosnia and Herzegovina)
| |
The association between airway hyperresponsiveness to mannitol and T2 inflammatory markers in asthma versus COPD D. Klein (Copenhagen, Denmark), T. Lapperre (Copenhagen, Denmark), M. Hvidtfeldt (Copenhagen, Denmark), A. Sverrild (Copenhagen, Denmark), U. Bødtger (Næstved, Denmark), K. Romberg (Höllviken, Sweden), L. Bjermer (Lund, Sweden), J. Erjefält (Lund, Sweden), K. Kristiansen (Copenhagen, Denmark), C. Porsbjerg (Copenhagen, Denmark)
| |
Non-contact Doppler radar screening system for the detection of COPD H. Nishine (Kawasaki, Japan), H. Takamoto (Hino, Japan), G. Sun (Chofu, Japan), S. Sato (Yokohama, Japan), T. Inoue (Kawasaki, Japan), T. Matsui (Hino, Japan), M. Mineshita (Kawasaki, Japan)
| |
Useful malnutrition diagnostic criteria for stable COPD in Japanese patients H. Nakamura (Sakaide kagawa, Japan), N. Kita (Sakaide kagawa, Japan), C. Kunikata (Sakaide kagawa, Japan), K. Tanimoto (Sakaide kagawa, Japan), T. Taoka (Sakaide kagawa, Japan)
| |
Feasibility of daily vital signs monitoring (VSM) in COPD G. France (Leicester, United Kingdom), N. Greening (Leicester, United Kingdom), D. Esliger (Loughborough, United Kingdom), M. Steiner (Leicester, United Kingdom), S. Singh (Leicester, United Kingdom), M. Orme (Leicester, United Kingdom)
| |
Heart remodeling in patients after St-segment elevation myocardial infarction with and without concomitant COPD. A. Balitskya (Barnaul, Russian Federation), E. Klester (Barnaul, Russian Federation), K. Klester (Barnaul, Russian Federation), V. Yarkova (Barnaul, Russian Federation), V. Nikitin (Yoshkar-Ola, Russian Federation)
| |
Screening for COPD with a portable spirometer among hospitalised smokers K. Mycroft (Warszawa, Poland), P. Jankowski (Warszawa, Poland), O. Zelazna (Warszawa, Poland), M. Zagaja (Warszawa, Poland), K. Wozniczko (Warszawa, Poland), U. Szafranska (Warszawa, Poland), M. Kutka (Warszawa, Poland), P. Korczynski (Warszawa, Poland), L. Koltowski (Warszawa, Poland), G. Opolski (Warszawa, Poland), R. Krenke (Warszawa, Poland), K. Gorska (Warszawa, Poland)
| |
Decaf score for predicting treatment escalation in exacerbations of COPD R. De Boer (Apeldoorn, Netherlands), M. Van Den Berg-Ter Veer (Apeldoorn, Netherlands), R. Sprooten (Maastricht, Netherlands), F. Franssen (Horn, Netherlands), S. Simons (Maastricht, Netherlands)
| |
Alveolar nitric oxide in a COPD cohort in Sweden over 2-year follow-up M. Högman (Uppsala, Sweden), A. Thornadtsson (Uppsala, Sweden), B. Ställberg (Uppsala, Sweden), K. Lisspers (Uppsala, Sweden), K. Bröms (Uppsala, Sweden), C. Janson (Uppsala, Sweden), A. Malinovschi (Uppsala, Sweden)
| |
Metronome-paced incremental hyperventilation can be used to predict dynamic lung hyperinflation and exercise tolerance during exercise S. Kawachi (Matsumoto, Japan), F. Keisaku (Matsumoto, Japan)
| |
History of pulmonary tuberculosis was associated with lung microbiome change in patients with chronic obstructive pulmonary disease Y. Chen (Douliou, Taiwan), H. Hou (Taipei, Taiwan), . Chien (Taipei, Taiwan), C. Shu (Taipei, Taiwan), S. Cheng (Taipei, Taiwan), H. Wang (Taipei, Taiwan), C. Yu (Taipei, Taiwan)
| |
How can we improve availability of quality assured spirometry for patients admitted with an exacerbation of COPD? C. Mooney (London, United Kingdom), L. Hone (London, United Kingdom), O. Atkins (London, United Kingdom)
| |